A detailed history of Commonwealth Equity Services, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 54,243 shares of CTMX stock, worth $59,124. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,243
Previous 54,243 -0.0%
Holding current value
$59,124
Previous $66,000 3.03%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$1.21 - $5.13 $1,210 - $5,130
1,000 Added 1.88%
54,243 $66,000
Q4 2022

Feb 07, 2023

BUY
$1.19 - $1.91 $63,359 - $101,694
53,243 New
53,243 $85,000

Others Institutions Holding CTMX

About CytomX Therapeutics, Inc.


  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $71.9M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.